India to extend price controls on drugsBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7462.368-c (Published 12 August 2004) Cite this as: BMJ 2004;329:368
- Sanjay Kumar
- New Delhi
India's minister for chemicals and fertilisers, Ram Vilas Paswan, has declared that the government will bring the prices of some 300 essential drugs under its control.
The move is seen as reversing the current trend of liberalisation. It aims to increase the affordability of drugs, as pharmaceutical companies were overcharging consumers. Currently, just 74 bulk drugs and their formulations are under price control.
Consumers are paying six to 32 times more than the retailers' purchase price for some drugs, says the chemicals ministry, referring to three drugs—nimesulide (an anti-inflammatory drug), omeprazole (a treatment for gastric ulcers), and cetrizine (an …
Log in using your username and password
Log in through your institution
Sign up for a free trial